HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Abstract
The authors reviewed contribution of Kumamoto University group to the progress of the studies on transthyretin (TTR)-related familial amyloidotic polyneuropathy (TTR-related FAP) for 42 years (from 1967 to 2009). Andrade (1952) first described a large group of patients with FAP in Portugal and Araki et al. (1967) in second discovered similar FAP patients in Arao, Kumamoto, Japan. Owing to progress in biochemical and molecular genetic analyses, FAP is now believed to occur worldwide. As of today, reports of about 100 different points of single or two mutations, or a deletion in the transthyretin (TTR) gene, have been published. The authors' group has made pioneer works for study of FAP in the world. The focus on therapy in amylodosis will increase sharply as an impetus in near future, and successful treatments are expected.
AuthorsShukuro Araki, Yukio Ando
JournalProceedings of the Japan Academy. Series B, Physical and biological sciences (Proc Jpn Acad Ser B Phys Biol Sci) Vol. 86 Issue 7 Pg. 694-706 ( 2010) ISSN: 1349-2896 [Electronic] Japan
PMID20689228 (Publication Type: Journal Article, Review)
Chemical References
  • Prealbumin
Topics
  • Amyloid Neuropathies, Familial (epidemiology, genetics, physiopathology, therapy)
  • Cities
  • Humans
  • Japan
  • Liver Transplantation
  • Prealbumin (chemistry, genetics, metabolism)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: